A clinical trial to evaluate the effect of dhatri lauha in the management of garbhini pandu (iron deficiency anemia)
Phase 2
- Conditions
- Health Condition 1: O280- Abnormal hematological finding onantenatal screening of mother
- Registration Number
- CTRI/2020/02/023577
- Lead Sponsor
- All india institute of ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
pregnant women with gestational age 16-18 weeks,having Hb% equal or less than 10gm% but more than 7.5gm%.
-Microcytic hypocromic appearance of RBC in peripheral smear.
-pregnant women,belonging to the age group of 18 to 35 years having clinical singh and symptoms of pandu like -panduta,hrudrava,shwasa,shothas.
-Subjects willing to participate in the study and provide signed informed consent.
Exclusion Criteria
-Pregnant women having Hb% count less than 7.5% and more than 10gm%.
-Pregnant women comeing with pregnancy related complications like PIH,hyperemesis gravidarum,pre eclampsia,diabetes,thyroid dysfunction etc.
-patients having high risk pregnancy.
-megaloblastic RBCs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of dhatri lauha in garbhini pandu in change in haemoglobin level.Timepoint: Hb% done after 15 days starting the treatment.if improved Hb% then will be continued again report 15th,20th,32th,36th,before term at the time of delivery.
- Secondary Outcome Measures
Name Time Method To evaluate the efficacy of dhatri lauha in garbhini pandu in change in haemoglobin level.Timepoint: Every 15th day in 4th to 6th month;every 8th day in 7th to 9th month